Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is a serine/threonine kinase involved in regulating multiple cellular processes, including cell proliferation, DNA damage repair, neuronal development, and apoptosis. Its overexpression in Down syndrome contributes to cognitive deficits, and mutations are linked to autism spectrum disorder and mental retardation. While it acts as oncogene or tumor suppressor in cancer, DYRK1A selective inhibitors are under investigation as potential therapeutics across numerous diseases.
DYRK1A inhibitors (various mechanisms)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A).